Technology & Software Global On demand · 24-48h

Global Sample Tracking Software Market Strategic Research Report

Name: Global Sample Tracking Software Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Sample Tracking Software Market Strategic Research Re…

$3,500 USD

Strategic Research Report

Global Sample Tracking Software Market

$8332025

6%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Local Deployment, Cloud-based

By Application: Medical and Clinical Testing, Biomedicine, CDC, Food and Agricultural Product Testing, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: LabWare, Thermo Scientific SampleManager, LabVantage, Benchling, STARLIMS, Azenta, Sapio Sciences, Titian, SciSure, Agilent SLIMS, Freezerworks, LabKey, QuartzBio, Autoscribe Informatics, Labguru, LabCollector, LABWORKS, LabLynx, Qingdao Haier Biomedical, Third Wave Analytics, TruLab, Withers, Zhong Lun Law Firm, AllBright Law Offices, Hilton Smythe

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 157 pages

Market size 2025

$833

Million USD

Forecast CAGR

2025-2032

Forecast 2032

$1252.5

Projected

区域

Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Sample Tracking Software market size is predicted to grow from US$ 833 million in 2025 to US$ 1,255 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

To address the problems of disorganized information recording, difficulty in traceability, and susceptibility to experimental data errors in traditional sample management, sample tracking software emerged. Since its inception in the early 21st century, sample tracking software has seen significant development in the fields of laboratory management and biobanks. Currently, sample tracking software has evolved into a comprehensive system encompassing routine sample tracking, biological sample traceability, and cold chain logistics monitoring, widely used in medical research, forensic identification, disease control centers, and biopharmaceuticals. It effectively ensures sample safety and reliability and improves the accuracy of experimental data.

The sample tracking software market is currently experiencing a dual opportunity period driven by technology and explosive demand, benefiting from the development of biotechnology, digital transformation, and policy support. The industry needs to address challenges through technological innovation (such as AI/blockchain), service upgrades (such as customized solutions and cloud services), and compliant operations (such as data security and privacy protection), seizing the growth opportunities brought by emerging industries, policy support, and technological integration. In the future, sample tracking software will upgrade towards intelligence, cloud computing, and integration, becoming an indispensable technological tool for research laboratories, medical institutions, and biopharmaceutical companies. This will drive the construction of a more efficient, safe, and sustainable sample management system, contributing to high-quality development in life sciences, healthcare, and environmental monitoring.

This report presents a comprehensive overview of the global Sample Tracking Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Local Deployment
Cloud-based

Segment by Technology Type

Blockchain Sample Tracking
RFID/NFC Sample Tracking

Segment by Data Type

Biological Sample Data Tracking
Environmental Data Tracking

Segment by Application

Medical and Clinical Testing
Biomedicine
CDC
Food and Agricultural Product Testing
Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sample Tracking Software market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Medical and Clinical Testing, Biomedicine, CDC evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Sample Tracking Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 6%

Regional growth momentum

Market share by segment

Key metrics

Base value

$833

2025

Forecast

$1252.5

2032

CAGR

2025–2032

区域

global

Key companies

LabWareThermo Scientific SampleManagerLabVantageBenchlingSTARLIMSAzentaSapio SciencesTitian

Segments covered in this report

By Type

Local DeploymentCloud-based

By Application

Medical and Clinical TestingBiomedicineCDCFood and Agricultural Product TestingOther

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Local Deployment
3.1.3 Cloud-based
3.1.4 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Medical and Clinical Testing
4.1.3 Biomedicine
4.1.4 CDC
4.1.5 Food and Agricultural Product Testing
4.1.6 Other
4.1.7 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 LabWare
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Thermo Scientific SampleManager
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 LabVantage
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Benchling
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 STARLIMS
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Azenta
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Sapio Sciences
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Titian
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 SciSure
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Agilent SLIMS
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Freezerworks
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 LabKey
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 QuartzBio
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Autoscribe Informatics
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Labguru
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 LabCollector
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 LABWORKS
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 LabLynx
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 Qingdao Haier Biomedical
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)
8.20 Third Wave Analytics
8.20.1 Company Overview
8.20.2 Key Products & Segments
8.20.3 Financial Performance (2023–2025)
8.20.4 Business Strategy
8.20.5 SWOT Analysis
8.20.6 Strategic Implications (2026–2032)
8.21 TruLab
8.21.1 Company Overview
8.21.2 Key Products & Segments
8.21.3 Financial Performance (2023–2025)
8.21.4 Business Strategy
8.21.5 SWOT Analysis
8.21.6 Strategic Implications (2026–2032)
8.22 Withers
8.22.1 Company Overview
8.22.2 Key Products & Segments
8.22.3 Financial Performance (2023–2025)
8.22.4 Business Strategy
8.22.5 SWOT Analysis
8.22.6 Strategic Implications (2026–2032)
8.23 Zhong Lun Law Firm
8.23.1 Company Overview
8.23.2 Key Products & Segments
8.23.3 Financial Performance (2023–2025)
8.23.4 Business Strategy
8.23.5 SWOT Analysis
8.23.6 Strategic Implications (2026–2032)
8.24 AllBright Law Offices
8.24.1 Company Overview
8.24.2 Key Products & Segments
8.24.3 Financial Performance (2023–2025)
8.24.4 Business Strategy
8.24.5 SWOT Analysis
8.24.6 Strategic Implications (2026–2032)
8.25 Hilton Smythe
8.25.1 Company Overview
8.25.2 Key Products & Segments
8.25.3 Financial Performance (2023–2025)
8.25.4 Business Strategy
8.25.5 SWOT Analysis
8.25.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Sample Tracking Software market size?

The global Sample Tracking Software market is estimated at US$ 833 million in 2025 (base year) and is projected to reach US$ 1.25 billion by 2032.

What growth rate is expected for the Sample Tracking Software market through 2032?

The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 833 million in 2025 to US$ 1.25 billion in 2032, roughly 1.5 times its base-year value.

How is Sample Tracking Software defined?

How is the Sample Tracking Software market segmented by type?

By type, the market is segmented into Local Deployment and Cloud-based.

What are the key applications of Sample Tracking Software?

Key applications covered include Medical and Clinical Testing, Biomedicine, CDC, Food and Agricultural Product Testing and Other.

Which companies are profiled in the Sample Tracking Software market report?

Key players profiled include LabWare, Thermo Scientific SampleManager, LabVantage, Benchling, STARLIMS, Azenta, Sapio Sciences and Titian, among 25 companies covered in total.

What geographies does the Sample Tracking Software market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the key demand drivers for Sample Tracking Software?

What are the main risks and barriers in the Sample Tracking Software market?

The industry needs to address challenges through technological innovation (such as AI/blockchain), service upgrades (such as customized solutions and cloud services), and compliant operations (such as data security and privacy protection), seizing the growth opportunities brought by emerging industries, policy support, and technological integration.

Who should buy the Sample Tracking Software market report?

The report is intended for manufacturers and solution providers, distributors and end users in Medical and Clinical Testing, Biomedicine and CDC, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Sample Tracking Software market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.